RESOLVE

NCT01534546 📎

Regimen

Experimental
perioperative SOX, or adjuvant SOX
Control
adjuvant CapOx

Population

Chinese patients with cT4aN+ or cT4bNany M0 gastric/GEJ cancer after D2 gastrectomy

Key finding

3y DFS 59.4% (periop-SOX) vs 51.1% (adj-CapOx), HR 0.77 (95% CI 0.61-0.97, p=0.028); adj-SOX 56.5% non-inferior to adj-CapOx

Source: PMID 34252374

Timeline

    Guideline citations

    • NCCN GASTRIC (p.136)
    • CSCO GASTRIC 2025 (p.63)⚠️ OCR source